ArticleHaematologica2014

Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia.

Catharina Müller-Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.